Alvotech (NASDAQ:ALVOW) Stock Price Up 37% – Still a Buy?
by Sarita Garza · The Markets DailyAlvotech (NASDAQ:ALVOW – Get Free Report) traded up 37% during trading on Thursday. The stock traded as high as $0.3799 and last traded at $0.37. Approximately 2,350 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 4,478 shares. The stock had previously closed at $0.27.
Alvotech Stock Performance
The stock has a fifty day simple moving average of $0.26 and a two-hundred day simple moving average of $0.25.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.